ACHIEVE LIFE SCIENCES INC
ACHVLatest QuantConomy context for ACHV: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
ACHIEVE LIFE SCIENCES INC
QuantConomy has a structured record for ACHV. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- ACHV
- Name
- ACHIEVE LIFE SCIENCES INC
- Coverage
- 3 market/data records
- Sources
- alpaca alphavantage fmp sec nasdaq openfigi
Recent signals for ACHV
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| downtrend | slightly bearish | 29 | Jul 10, 07:59 PM | ACHV downtrend (drop): price -1.45% (strength 29, current 6.12) |
| sustained dry up | neutral | 61 | Jul 10, 06:02 PM | ACHV sustained volume dry-up: 10% of expected volume for Friday 18:00 UTC, price flat 0.00% (strength 61) |
| sustained dry up | neutral | 37 | Jul 10, 05:01 PM | ACHV sustained volume dry-up: 20% of expected volume for Friday 17:00 UTC, price flat 0.25% (strength 37) |
EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).
PRICE signals are experimental: realized 30-day directional accuracy is ~18% (short-horizon price moves tend to mean-revert). They are automatically down-weighted in composite scores but served raw here. Do not use them as standalone trade advice.
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| ACHV | NASDAQ | alpaca | Achieve Life Sciences, Inc. Common Shares |
| ACHV | NASDAQ | alphavantage | Achieve Life Sciences Inc |
| ACHV | NASDAQ | fmp | Achieve Life Sciences, Inc. |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| — | Waldman Reid Alexander | Director | — | — | — | — | 3 on EDGAR |
| May 29, 2026 | Waldman Reid Alexander | Director | grant | 47,250 | — | — | 4 on EDGAR |
| May 29, 2026 | Farrow Jeffrey S | Director | grant | 47,250 | — | — | 4 on EDGAR |
| — | Farrow Jeffrey S | Director | — | — | — | — | 3 on EDGAR |
| May 11, 2026 | Martin Christopher Nathan | Director | grant | 47,250 | — | — | 4 on EDGAR |
| — | Martin Christopher Nathan | Director | — | — | — | — | 3 on EDGAR |
| Apr 18, 2026 | Goldberg Andrew D. | CEO and President | grant | 1,800,965 | — | — | 4 on EDGAR |
| — | Goldberg Andrew D. | CEO and President | — | — | — | — | 3 on EDGAR |
| — | Iancovici Lucian | Insider | — | — | — | — | 3 on EDGAR |
| — | Royston Aaron | Director | — | — | — | — | 3 on EDGAR |
| — | TPG GP A, LLC | Insider | — | — | — | — | 3 on EDGAR |
| — | Rubinstein Mark Lawrence | Chief Medical Officer | — | — | — | — | 3 on EDGAR |
| Dec 4, 2025 | Atkisson Erik | Chief Legal Officer | grant | 250,000 | — | — | 4 on EDGAR |
| Jan 28, 2026 | Stewart Richard Alistair | Chief Executive Officer | grant | 645,000 | — | — | 4 on EDGAR |
| Jan 28, 2026 | Rubinstein Mark Lawrence | Chief Medical Officer | grant | 180,000 | — | — | 4 on EDGAR |
| Jan 28, 2026 | Xinos Jaime | Chief Commercial Officer | grant | 180,000 | — | — | 4 on EDGAR |
| Jan 28, 2026 | Donnelly Craig | Chief Operations Officer | grant | 180,000 | — | — | 4 on EDGAR |
| Jan 28, 2026 | Oki Mark K | Chief Financial Officer | grant | 180,000 | — | — | 4 on EDGAR |
| Jan 28, 2026 | Wan Jerry | Principal Accounting Officer | grant | 70,300 | — | — | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query ACHV context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access